These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8222638)
41. American Academy of Pediatrics Committee on Drugs: Clioquinol (iodochlorhydroxyquin, vioform) and iodoquinol (diiodohydroxyquin): blindness and neuropathy. Pediatrics; 1990 Nov; 86(5):797-8. PubMed ID: 2146587 [No Abstract] [Full Text] [Related]
42. Blindness and neuropathy from diiodohydroxyquin-like drugs. Committee on drugs. Pediatrics; 1974 Sep; 54(3):378-9. PubMed ID: 4278011 [No Abstract] [Full Text] [Related]
43. [Therapeutic efficacy of the combination of chlorquinaldol plus promestriene in infections of the vagina]. Palacios Gil-Antuñano S Rev Clin Esp; 1984 Jun 15-30; 173(5-6):297-300. PubMed ID: 6494525 [No Abstract] [Full Text] [Related]
44. The inhibitory effects of topical chelating agents and antioxidants on nickel-induced hypersensitivity reactions. Memon AA; Molokhia MM; Friedmann PS J Am Acad Dermatol; 1994 Apr; 30(4):560-5. PubMed ID: 8157781 [TBL] [Abstract][Full Text] [Related]
45. [Prospective study on the side-effects of the clioquinol preparation mexaform with special reference to subacute myelo-optic neuropathy]. Bezjak B; Breintenfeld V; Schönwald S; Car V; Puskarić-Hamel N; Vrancić J; Hotujac L Lijec Vjesn; 1974 Sep; 96(9):553-6. PubMed ID: 4281043 [No Abstract] [Full Text] [Related]
46. [Diflucortolone valerate and chlorquinaldol in topical eczema (in single or combination form)]. Solaroli C; Sgarbanti E G Ital Dermatol Venereol; 1987 May; 122(5):XXXI-XXXIII. PubMed ID: 3623611 [No Abstract] [Full Text] [Related]
47. [Welcome clarifications from CIBA-GEIGY]. Hansson O Lakartidningen; 1977 Sep; 74(37):3095-7. PubMed ID: 143555 [No Abstract] [Full Text] [Related]
48. Chlorquinaldol ("Steroxin") with hydrocortisone in the therapy of common dermatoses. Rosanove R Med J Aust; 1966 Jan; 1(2):54-5. PubMed ID: 5902021 [No Abstract] [Full Text] [Related]
49. [Double blind study with diflucortolone valerianate and chlorquinaldol, comparison with placebo in various dermatosis]. Arias Gómez O Alergia; 1977 Apr; 24(2):85-9. PubMed ID: 331993 [No Abstract] [Full Text] [Related]
50. Clioquinol treatment in familiar early onset of Alzheimer's disease: a case report. Ibach B; Haen E; Marienhagen J; Hajak G Pharmacopsychiatry; 2005 Jul; 38(4):178-9. PubMed ID: 16025421 [TBL] [Abstract][Full Text] [Related]
51. [Topical treatment of various dermatoses with 0.1% difluocartolone valerate with 1% chlorquinaldol (cream)]. Ogarrio González SR Prensa Med Mex; 1977; 42(1-2):103-5. PubMed ID: 896646 [No Abstract] [Full Text] [Related]
52. Transient dysaesthesiae and persistent leucocytosis after clioquinol therapy. Terry SI Br Med J; 1971 Sep; 3(5777):745. PubMed ID: 4329043 [No Abstract] [Full Text] [Related]
53. [Elaboration of the method of obtaining aerosols containing vioform and chlorchinaldin, and their clinical evaluation]. Zakrzewski Z; Chadzyńska M; Moskalewska K; Pietura A; Dabrowska H; Katarzyńska U Przegl Dermatol; 1982; 69(4):295-9. PubMed ID: 6223339 [No Abstract] [Full Text] [Related]
54. Comparison of Chlorquinaldol-Promestriene Vaginal Tablets and Opin Suppositories Effect on Inflammatory Factors and Immune Function in Chronic HPV Cervicitis. Chen X; Guo H J Coll Physicians Surg Pak; 2019 Feb; 29(2):115-118. PubMed ID: 30700347 [TBL] [Abstract][Full Text] [Related]
55. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Ritchie CW; Bush AI; Mackinnon A; Macfarlane S; Mastwyk M; MacGregor L; Kiers L; Cherny R; Li QX; Tammer A; Carrington D; Mavros C; Volitakis I; Xilinas M; Ames D; Davis S; Beyreuther K; Tanzi RE; Masters CL Arch Neurol; 2003 Dec; 60(12):1685-91. PubMed ID: 14676042 [TBL] [Abstract][Full Text] [Related]